sentence_eng_Latn: Study 316 was a randomised, double-blind trial of posaconazole oral suspension (200 mg three times a day) versus fluconazole capsules (400 mg once daily) in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease (GVHD).
sentence_dyu_Latn: Bara 316 tou yé kunfè ko lé yé, figué tigui tigui ta manfilè ni posaconazole mi ta yé (200 mg segnan saba lon kélé) (400 mg schien kélé télé kônôn) allogeneic hematopoietic stem farissogo kissè yèlèman bana baga to mi yé ni graft-versus-host (GVHD) yé ahi la.